Compare MD & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MD | NGVT |
|---|---|---|
| Founded | 1979 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 1996 | 2015 |
| Metric | MD | NGVT |
|---|---|---|
| Price | $26.13 | $75.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $20.50 | ★ $72.50 |
| AVG Volume (30 Days) | ★ 773.7K | 287.7K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 263.03 | 61.10 |
| EPS | 0.36 | ★ 1.66 |
| Revenue | ★ $1,913,849,000.00 | $1,167,600,000.00 |
| Revenue This Year | $3.72 | $3.63 |
| Revenue Next Year | $2.62 | $0.50 |
| P/E Ratio | $73.13 | ★ $45.08 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.84 | $39.74 |
| 52 Week High | $28.86 | $79.29 |
| Indicator | MD | NGVT |
|---|---|---|
| Relative Strength Index (RSI) | 57.16 | 61.37 |
| Support Level | $20.43 | $63.91 |
| Resistance Level | $28.86 | $77.62 |
| Average True Range (ATR) | 1.06 | 2.34 |
| MACD | -0.11 | 0.15 |
| Stochastic Oscillator | 45.29 | 82.96 |
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.